Acta Scientific Pharmacology (ASPC)

Editorial Volume 1 Issue 3

Hepatocellular Carcinoma is a Global Burden

Yomna S Mo’men*

Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

*Corresponding Author: Yomna S Mo’men, Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

Received: January 02, 2019; Published: February 01, 2020


  Hepatocellular carcinoma is the most common primary hepatic neoplasia that ranked second among cancer related mortality worldwide. HCC is predominant in Asia and Sub-Saharan Africa with lower prevalence in the Eastern Mediterranean countries and western societies. In addition, almost 50% of newly diagnosed HCC cases occur in China. Moreover, In the USA, the HCC incidence rates have doubled over the past two decades [1].

  The increase in HCC incidence globally could be attributed to many factors. First the continuous increase in the number of patients with hepatitis C virus (HCV)-related cirrhosis whereas liver cirrhosis is the primary predisposing factor for HCC. Other cirrhosis risk factors include alcohol abuse and non-alcoholic fatty liver disease. In addition, HCC can develop in patients with chronic liver disease without underlying cirrhosis. Among patients with non‐cirrhotic HCC, 20% had Fibrosis‐4 (FIB‐4) >3.6 and 45% had FIB‐4 1.6‐3.6, while NASH accounts for 26.3% of non-cirrhotic HCC cases. Furthermore, metabolic and genetic diseases associated with HCC are hemochromatosis, Wilson's disease, α-1 antitrypsin disease, tyrosinemia, glycogen storage types I and II, and porphyrias [2].



Citation: Yomna S Mo’men. “Hepatocellular Carcinoma is a Global Burden”.Acta Scientific Pharmacology 1.3 (2020): 01.


Acceptance rate36%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US